PET with CTC detects polyps well, requires no cleansing
PET with CT colonography provides an alternative for detecting polyps and cancer in the colon, according to a study published in the Journal of Nuclear Medicine. PET with CT colonography (CTC) is especially helpful because it does not require bowel preparation.
The study, involving 56 patients, is the largest to date investigating PET CTC in patients without bowel preparation. The patients underwent a PET CTC two weeks before their scheduled colonoscopy, the standard diagnostic test for colorectal cancer.
CTC sensitivity for polyps 6 mm or larger was 92.9% and was not improved by the addition of PET. But by combining PET with CTC, per-patient positive predictive value for a polyp 10 mm or greater jumped from 73% to 100% (J Nucl Med 2010;51:854-861).
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
